You just read:

Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronie's Disease

News provided by

Auxilium Pharmaceuticals, Inc.

Mar 09, 2011, 07:00 ET